Jpmorgan Chase & CO Apyx Medical Corp Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Apyx Medical Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 67 shares of APYX stock, worth $105. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 67 -0.0%

Holding current value

$105

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$1.26 - $1.66 $3 - $4	-3 Reduced 4.29%	67 $0
Q1 2024 May 10, 2024	SELL	$1.25 - $2.71 $941 - $2,040	-753 Reduced 91.49%	70 $0
Q4 2023 Feb 12, 2024	SELL	$1.49 - $3.25 $233,988 - $510,376	-157,039 Reduced 99.48%	823 $2,000
Q3 2023 Nov 14, 2023	SELL	$3.07 - $6.2 $18,895 - $38,161	-6,155 Reduced 3.75%	157,862 $505,000
Q2 2023 Aug 11, 2023	SELL	$2.75 - $7.59 $764,711 - $2.11 Million	-278,077 Reduced 62.9%	164,017 $825,000
Q1 2023 May 11, 2023	BUY	$2.45 - $3.59 $330,345 - $484,057	134,835 Added 43.88%	442,094 $1.27 Million
Q4 2022 Feb 13, 2023	BUY	$1.4 - $5.02 $332,669 - $1.19 Million	237,621 Added 341.22%	307,259 $719,000
Q3 2022 Nov 14, 2022	SELL	$4.49 - $10.83 $60,336 - $145,533	-13,438 Reduced 16.18%	69,638 $313,000
Q2 2022 Aug 11, 2022	SELL	$3.11 - $7.5 $234,357 - $565,170	-75,356 Reduced 47.56%	83,076 $487,000
Q1 2022 May 11, 2022	SELL	$5.87 - $13.13 $148,129 - $331,335	-25,235 Reduced 13.74%	158,432 $1.04 Million
Q4 2021 Feb 10, 2022	SELL	$12.15 - $17.4 $14,312 - $20,497	-1,178 Reduced 0.64%	183,667 $2.36 Million
Q3 2021 Nov 12, 2021	BUY	$8.79 - $13.96 $1.62 Million - $2.58 Million	184,845 New	184,845 $2.56 Million

Others Institutions Holding APYX

# of Institutions

Shares Held

14.3M

Call Options Held

353K

Put Options Held

1.6K

View Full List

About Apyx Medical Corp

Ticker APYX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 34,573,000
Market Cap $54.3M
Description
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ab...

More about APYX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Apyx Medical Corp Transaction History